🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

One week to #ASCO25. Which will be an unprecedented ASCO for breast oncologists. Treatment algorithms will change for ALL disease subtypes. ADCs will climb to earlier lines of treatment. Paradigms will be challenged. Here’s my list of top 10 abstracts. See you in Chicago! #bcsm

Registration is OPEN! Join us Oct 27–29, 2025 in Boston for the SIO 22nd International Conference, hosted with Dana-Farber’s Zakim Center. The Future of Integrative Oncology: Bridging Cultures, Embracing Innovation, and Fostering Unity Register now integrativeonc.org/registration/

Dana-Farber’s Breast Oncology Center and Dana-Farber Zakim Center are leading a Randomized Phase III Clinical Trial of #Acupuncture for Chemotherapy-Induced Peripheral Neuropathy (#CIPN) Treatment. For more information email [email protected] or visit rally.massgeneralbrigham.org/study/actstudy Study PI: Ting Bao, MD

Dr. Sara Tolaney (Sara Tolaney) presents the practice changing results from the 3 ASCENT-04/KEYNOTE-D19 study at #ASCO25, which support the use of #SacituzumabGovitecan + #Pembrolizumab as a potential new standard of care for patients with previously untreated, PD-L1+, locally

From research to guidelines but unless we implement these interventions into standard cancer care, we are not truly helping people impacted by cancer.

The curves everybody’s been waiting for. First line T-DXd + pertuzumab significantly prolonged PFS over THP for HER2+ MBC (40.7 vs 26.9 months, HR 0.56, p<0.001), doubled the rate of complete responses (15% vs 8%) and had a positive OS trend (HR 0.84). Practice changing data.

Dr Kathryn Schmitz ASCO Thank you Dr Kathryn Schmitz for posting. We created a video companion for the CHALLENGE Trial results here: x.com/oncologytube/s…

Excited to welcome Dr. Helene Langevin, Director of NIH NCCIH, as keynote! She’ll speak on Expressive Art and Cancer, bridging science & creativity in healing. A leader in IM, Dr. Langevin brings decades of research and clinical insight. Register:integrativeonc.org/registration/

An anti-inflammatory diet may help colon cancer patients live longer, study says. Dana-Farber’s Sara Khosrowjerdi Char, MD and Kimmie Ng, MD, MPH talked with NBC News about their research on diet and #coloncancer presented at #ASCO25: bit.ly/451IZOb

👏Congratulations to Dana-Farber's Filipa Lynce, MD, FASCO (Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸), recipient of the Advanced Clinical Research Award in #BreastCancer Research from Conquer Cancer, the ASCO Foundation. Dr. Lynce's work will focus on deciphering mechanisms of response to novel therapies in HER2 expressing

Join us in Boston!

Chemotherapy can save lives, but it can also come with challenges like #PeripheralNeuropathy. Ting Bao, MD, MS, (Ting Bao, MD) co-director of the Dana-Farber Zakim Center breaks down #ChemotherapyInducedPeripheralNeuropathy. Watch the webinar to learn about the causes, symptoms, risk

Very excited the primary psychosocial outcomes of the MATCH (Mindfulness and Taichi for Cancer Health) trial were published today in the ASCO Journal of Clinical Oncology. Largest comparative trial of #mindbody therapies to date. Free full-text here: ascopubs.org/doi/pdf/10.120…

Registration is OPEN! Join us Oct 27–29, 2025 in Boston for the SIO 22nd International Conference, hosted with Dana-Farber’s Zakim Center. The Future of Integrative Oncology: Bridging Cultures, Embracing Innovation, and Fostering Unity Register now integrativeonc.org/registration/

Dana-Farber’s Breast Oncology Center and Dana-Farber Zakim Center are leading a Randomized Phase III Clinical Trial of #Acupuncture for Chemotherapy-Induced Peripheral Neuropathy (#CIPN) Treatment. For more information email: [email protected] or visit rally.massgeneralbrigham.org/study/actstudy Study PI:

Judith Lacey gave an overview on the role of #integrative medicine in managing the emerging toxicities that people living with #cancer face. Society for Integrative Oncology MASCC #MASCC25

Judith Lacey Society for Integrative Oncology MASCC Ting Bao, MD shared her 15-year journey of conducting acupuncture clinical trials aimed at treating chemotherapy-induced neuropathy in patients with #cancer. Society for Integrative Oncology MASCC #MASCC25

Judith Lacey Society for Integrative Oncology MASCC Ting Bao, MD Dr Heather Greenlee discussed the Society for Integrative Oncology - ASCO partnership in developing evidence-based guidelines on the use of integrative medicine in oncology. #MASCC25

It was a wonderful gathering with MASCC leaders at Professor Heather Greenlee’s home in Seattle. I hope SIO and MASCC will collaborate closely soon to enhance the quality of life for cancer survivors. MASCC Society for Integrative Oncology Dana-Farber Zakim Center Dana-Farber’s Breast Oncology Center